BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bioinformatics Software | QIAGEN Digital Insights - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bioinformatics Software | QIAGEN Digital Insights
X-ORIGINAL-URL:https://staging.digitalinsights.supremeclients.com
X-WR-CALDESC:Events for Bioinformatics Software | QIAGEN Digital Insights
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20230511T130000
DTEND;TZID=UTC:20230511T143000
DTSTAMP:20260504T063440
CREATED:20230418T123154Z
LAST-MODIFIED:20241024T182855Z
UID:10000632-1683810000-1683815400@staging.digitalinsights.supremeclients.com
SUMMARY:Checkpoint inhibitors in the context of biomarkers\, drug targets and pathways
DESCRIPTION:In this training\, we will focus on how you can use QIAGEN Omicsoft Studio and QIAGEN Ingenuity Pathway Analysis (IPA) to discover new biomarkers\, validate (or study) drug targets and identify novel mechanisms of action with your own and/or public checkpoint inhibitor datasets from resources like GEO\, SRA\, TCGA and more. \nIn this training\, you’ll learn how to: \n· Investigate the expression of a gene/biomarker/drug target across different treatments and diseases \n· Derive a biomarker/gene signature from a specific condition (for example\, non-responders of a drug\, or a particular disease/disease subtype and others) \n· Correlate expression of multiple genes and biomarkers \n· Compare different experimental groups (e.g.\, your own data and/or public data) at both the levels of gene expression and pathways/regulatory networks activity
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/checkpoint-inhibitors-in-the-context-of-biomarkers-drug-targets-and-pathways/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
END:VCALENDAR